Jajati Keshari Sahu

Jajati Keshari Sahu

Active Director Managing Director DIN 08194568
DIN 08194568 First appointment Aug 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Jajati Keshari Sahu

Data last updated:

Jajati Keshari Sahu is a Managing Director at Aelix Pharmaceutical Private Limited (since 2018). The company operates in Pharma.

DIN 08194568
Primary Designation Managing Director
Industry Pharma
First Appointment 06 Aug 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aelix Pharmaceutical Private Limited U51909OR2018PTC029264
Managing Director06 Aug 20182018Active

Board colleagues of Jajati Keshari Sahu

Directorship timeline

Open interactive timeline →
Aelix Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Jajati Keshari Sahu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jajati Keshari Sahu

Jajati Keshari Sahu currently holds 1 directorship: Aelix Pharmaceutical Private Limited (Managing Director, since 06 Aug 2018).

Jajati Keshari Sahu was first appointed on 06 Aug 2018 as Managing Director at Aelix Pharmaceutical Private Limited.

The current boards of Jajati Keshari Sahu's companies include Geetanjali Das (Aelix Pharmaceutical Private Limited), Kabir Das (Aelix Pharmaceutical Private Limited), Moumee Sahu (Aelix Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available